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Apoε4 disrupts neurovascular regulation and
undermines white matter integrity and cognitive
function
Kenzo Koizumi1, Yorito Hattori1, Sung Ji Ahn1, Izaskun Buendia1, Antonio Ciacciarelli 1, Ken Uekawa1,
Gang Wang1, Abigail Hiller1, Lingzhi Zhao1, Henning U. Voss 2, Steven M. Paul3, Chris Schaffer 1,4,
Laibaik Park 1 & Costantino Iadecola1
The ApoE4 allele is associated with increased risk of small vessel disease, which is a cause of
vascular cognitive impairment. Here, we report that mice with targeted replacement (TR) of
the ApoE gene with human ApoE4 have reduced neocortical cerebral blood ﬂow compared to
ApoE3-TR mice, an effect due to reduced vascular density rather than slowing of micro-
vascular red blood cell ﬂow. Furthermore, homeostatic mechanisms matching local delivery
of blood ﬂow to brain activity are impaired in ApoE4-TR mice. In a model of cerebral
hypoperfusion, these cerebrovascular alterations exacerbate damage to the white matter of
the corpus callosum and worsen cognitive dysfunction. Using 3-photon microscopy we found
that the increased white matter damage is linked to an enhanced reduction of microvascular
ﬂow resulting in local hypoxia. Such alterations may be responsible for the increased sus-
ceptibility to hypoxic-ischemic lesions in the subcortical white matter of individuals carrying
the ApoE4 allele.
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M icrovascular alterations leading to hypoxic-ischemicwhite matter (WM) damage (small vessels disease,SVD) are the major cause of cognitive impairment on
vascular basis1, and have also been implicated in cognitive dys-
function and amyloid-β accumulation in Alzheimer’s disease
(AD)2–4. The pathogenic mechanisms by which SVD leads to
WM damage remain to be established. Supplied by terminal
arterioles in overlapping arterial territories, the subcortical WM is
thought to be particularly vulnerable to vascular dysfunction and
reduced cerebral perfusion5. However, little is known about the
microcirculation of the deep cortical WM and the impact that
cerebral hypoperfusion exerts on WM microvascular ﬂow.
Although vascular risk factors, hypertension in particular, are
well known causes of small vessel diseases and WM damage6,
genetic factors also play a role7. In particular, the ApoE4 allele,
the leading genetic risk factor for sporadic AD, has also emerged
as a risk factor for SVD and cognitive impairment on vascular
basis8–10. Thus, individuals homozygous for ApoE4 have 3–4 fold
increased risk of WM lesions, independently of other risk factors,
such as age and hypertension, or AD diagnosis11–13. An asso-
ciation with microbleeds has also been reported14, but it is
unclear if it reﬂects cerebral amyloid angiopathy, for which
ApoE4 is also a risk factor15, possibly by impairing Aβ vascular
clearance16.
The mechanisms by which the ApoE4 may promote WM
damage remain to be explored. Healthy individuals carrying the
ApoE4 allele have reduced cerebral blood ﬂow (CBF)17, whereas
mice with targeted replacement of ApoE with human ApoE4 have
altered permeability of the blood brain barrier (BBB), an effect
attributed to age-dependent pericyte loss18. However, whether
ApoE4 alters microvascular function and promotes WM ischemic
lesions remains to be established.
In this study, we used ApoE4-targeted replacement mice
(ApoE4-TR) to gain insight into the increased susceptibility to
WM damage conferred by the ApoE4 allele. We found major
alterations in microvascular regulation in ApoE4-TR mice,
associated with an increased susceptibility to WM damage and
cognitive impairment in cerebral hypoperfusion produced by
bilateral carotid artery stenosis (BCAS). Microvascular imaging
with 3-photon microscopy revealed a remarkable susceptibility of
WM microvascular ﬂow to hypoperfusion leading to WM
hypoxia and damage. The ﬁndings provide insight into the
microvascular events underlying hypoxic-ischemic damage of
the deep cortical WM and unveil a potential mechanism for the
increased WM lesion burden in ApoE4 carriers.
Results
Resting CBF is reduced in ApoE4-TR mice. First, we examined
the impact of ApoE4 on baseline cerebral perfusion. To this end,
we used ASL-MRI to measure CBF quantitatively (ml/100 g/min)
in wild-type (WT), ApoE3-TR and ApoE4-TR mice. No differ-
ence in mean arterial pressure was found between WT [83
(mean) ± 3 (SEM) mmHg), ApoE3-TR (84 ± 3 mmHg) and
ApoE4-TR mice (81 ± 2 mmHg). In ApoE3 mice somatosensory
cortex CBF was not different from that of WT mice (Fig. 1a), but
was reduced by 19 ± 4% in ApoE4-TR vs. WT mice and by 13 ±
5% vs. ApoE3-TR mice (Fig. 1a; p < 0.05). CBF was also reduced
in the caudate nucleus in ApoE4-TR vs. WT mice (−14 ± 4%
Supplementary Fig. 1A; p < 0.05). To provide insight into the
microvascular bases of the reduction in resting CBF, we used
in vivo 2-photon microscopy to assess microvascular diameter
and red blood cell (RBC) speed in the neocortex. We focused on
the somatosensory cortex, the same area where CBF was mea-
sured by ASL-MRI, under the same conditions of anesthesia and
physiological parameters. Microvascular networks (arterioles,
capillaries, venules) were identiﬁed by morphological criteria and
direction of ﬂow and reconstructed19. We found that vascular
diameter and RBC velocity in these microvessels did not differ
between ApoE3-TR and ApoE4-TR mice (Fig. 1b).
To determine if the reduction in neocortical CBF was the result
of reduced vascular density, we examined microvascular density
using the endothelial markers CD31 and Glut-1. We found a
reduction in the number and area of CD31-positive microvessels
in the neocortex and corpus callosum (CC) of ApoE4-TR mice
compared to WT and ApoE3-TR mice (Fig. 1c; p < 0.05). A
reduction in vascular density in neocortex was also observed with
Glut-1 as a marker (Supplementary Fig. 1B), an effect
independent of neocortical atrophy assessed by measurement of
cortical thickness with MRI (Supplementary Fig. 1C). As
previously reported18, pericyte coverage of cortical microvessels,
assessed by CD13 immunocytochemistry, was reduced in ApoE4-
TR compared to WT and ApoE3-TR mice (Supplementary
Fig. 2A–D). Therefore, vascular density and resting cerebral
perfusion are reduced in ApoE4-TR mice, which, in the absence
of blood pressure changes, suggests an increase in cerebrovascular
resistance compared to ApoE3-TR mice.
Radical-dependent neurovascular dysfunction in ApoE4-TR
mice. Owing to limited energy stores, the brain relies on a con-
tinuous delivery of oxygen and glucose through blood ﬂow, and,
consequently, critical regulatory mechanisms assure that the
brain’s blood supply is well matched to the local metabolic needs
of the tissue20. Alterations in CBF regulation cause brain dys-
function, often resulting in cognitive impairment5. Therefore, we
investigated if key mechanisms regulating CBF, such as the
coupling between neural activity and CBF, and the endothelial
regulation of microvascular ﬂow, are altered by ApoE4. ApoE3-
TR, ApoE4-TR, and WT mice were equipped with a cranial
window overlying the whisker barrel cortex and CBF responses to
neural activity (whisker stimulation) and to neocortical super-
fusion with the endothelium-dependent vasoactive agents acet-
ylcholine (ACh) and bradykinin (BK) were tested using laser-
Doppler ﬂowmetry (LDF). CBF responses to superfusion of the
smooth muscle relaxants adenosine and the nitric oxide (NO)
donor S-nitroso-N-acetylpenicillamine (SNAP), as well as
hypercapnia, a potent vasodilatatory stimulus, were also exam-
ined. We found that the increase in somatosensory cortex CBF
evoked by whisker stimulation, as well as those produced by
neocortical application of ACh or BK was markedly reduced in
ApoE4-TR mice (Fig. 2a–c; Supplementary Fig. 3A). In contrast,
responses to adenosine, SNAP, and hypercapnia were not affected
(Fig. 2d; Supplementary Fig. 3B–C), attesting to the selectivity of
the effect of ApoE4 on endothelium-dependent responses and
neurovascular coupling. The attenuation in neurovascular cou-
pling is unlikely to result from an impairment of glutamate
receptor function and reduced Ca2+ inﬂux, critical drivers of the
CBF increase evoked by neural activity in the whisker barrel
cortex21. This is because the increase in intracellular Ca2+
induced by the glutamatergic agonist N-methyl-D-aspartate
(NMDA) in isolated neocortical neurons was comparable
between WT, ApoE3-TR and ApoE4-TR mice (Supplementary
Fig. 4). Similarly, the presynaptic marker synaptophysin was not
reduced in the neocortex of ApoE4-TR mice (Supplementary
Fig. 5). Since oxidative stress has been associated with SVD in
humans22 and ApoE4 increases production of reactive oxygen
species (ROS)23, we examined the role of oxidative stress in the
neurovascular dysfunction of ApoE4-TR mice. Neocortical
superfusion with the ROS scavenger MnTBAP for 30–45 min did
not ameliorate resting CBF, but completely rescued neurovascular
coupling and endothelium-dependent responses to ACh
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(Fig. 2a–c; Supplementary Fig. 6), implicating ROS in the
mechanisms of the neurovascular dysfunction.
BCAS induces more marked CBF reductions in ApoE4-TR
mice. Considering their lower resting CBF and impaired neuro-
vascular reactivity, we hypothesized that ApoE4-TR mice would
be more susceptible to the hypoperfusion produced by BCAS24.
Mice were equipped with bilateral LDF probes overlying the
somatosensory cortex for chronic recording of CBF bilaterally
(Fig. 3a). To reduce arterial diameter, 0.18 mm microcoils were
placed around both common carotid arteries, and the corre-
sponding reductions in cortical CBF were monitored at different
time points (Fig. 3a, b; Supplementary Fig. 7A). In WT and
ApoE3-TR mice, BCAS induced a reduction in CBF, which was
greatest at 2 h (−40%) and remained suppressed 4 weeks later
(−30%) (Fig. 3a, b). Using the resting CBF value provided by
ASL-MRI (Fig. 1a) and the % reduction provided by LDF
(Fig. 3a), we calculated in WT mice that cortical CBF was 77 ± 4
ml/100/min at 2 h and 99 ± 2 ml/100/min 4 weeks after BCAS
(Supplementary Fig. 7B). However, in ApoE4-TR mice the
reduction in CBF was more severe compared to WT and ApoE3-
TR mice (p < 0.05)(Fig. 3a; Supplementary Fig. 7B). Using laser
speckle imaging (LSI), we conﬁrmed that the reduction in CBF
involves the entire neocortical mantle and is similar in magnitude
and time course to that observed with LDF (Fig. 3b; Supple-
mentary Fig. 7C). Therefore, the reduction in neocortical CBF
produced by BCAS is more pronounced in ApoE4-TR mice.
BCAS slows blood ﬂow in CC more markedly in ApoE4-TR
mice. To determine whether BCAS reduces cerebral perfusion
also in the WM of the CC of ApoE4-TR mice, we imaged RBC
ﬂow in CC microvessels before and 4 weeks after BCAS in the
same mice using 3-photon microscopy25. The vasculature of the
CC, ≈900 µm below the pial surface, was imaged and micro-
vascular diameter and RBC speed were measured using line
scanning19,25 (Fig. 4a–e). At baseline, microvascular diameter did
not differ between ApoE3-TR and ApoE4-TR mice, but RBC
speed was slower in ApoE4-TR mice (Fig. 4f, g). Following BCAS,
RBC speed decreased in both strains of mice, but the ﬂow
reduction was more severe in ApoE4-TR than in ApoE3-TR mice
(Fig. 4g).
BCAS damages WM and cognition more severly in ApoE4-TR








































































































































CD31+ vesselsa b c
Fig. 1 Reduced cortical CBF and vascular density in ApoE4-TR mice. a Neocortical CBF, assessed by ASL-MRI, is lower in ApoE4-TR mice, compared to WT
and ApoE3 mice. Scale bar= 1 mm. b. RBC speed in neocortical vessels (depth= 200 µm) in ApoE3-TR and ApoE4-TR mice assessed by 2-photon
microscopy after injection of FITC-labeled dextran to label the vasculature. Top two images show the microvasculature in ApoE3 and ApoE4 mice. The
colored rectangles indicate the location of the vessels (arterioles, capillaries, and venules) in which line scans were obtained to determine RBC speed (right
panels). The bottom graph shows the RBC speed measured by line scans as function of the vessel diameter: arterioles (>10 µm) to the left, capillaries in the
middle (≤10 µm; placed on arteriole or venule side depending on whether they were topologically closer to an arteriole or venule) and venules (>10 µm) to
the right (ApoE3 n= 166 vessels in four mice, ApoE4 n= 197 vessels in four mice). Scale bars are 100 µm, 50 µm, 100ms, respectively, for the large, small,
and line scan images. c CD31+ microvessels are reduced in ApoE4 mice both in neocortex and CC. Scale bar= 250 µm. The ApoE3-TR mice did not differ
from WT mice (p > 0.05). Data are expressed as means ± SEM. N= 5/group in a and c; *p < 0.05; one-way ANOVA and Tukey’s test
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in ApoE4-TR mice, we examined the degree of local hypoxia
produced by BCAS in the CC using the hypoxyprobe. We found
that the intensity of the hypoxia signal was more marked in
ApoE4-TR than in ApoE3-TR and WT mice (Fig. 3c), suggesting
that the greater reduction in WM CBF resulted in more severe
WM hypoxia in ApoE4-TR mice. To determine if the more severe
brain WM hypoperfusion and hypoxia in ApoE4-TR mice
resulted in a worse cognitive outcome, we investigated the WM
damage produced by BCAS and the attendant cognitive deﬁcits in
ApoE3-TR and ApoE4-TR mice. To this end, we examined
indices of WM integrity 4 weeks after BCAS, when the damage is
well developed24. BCAS resulted in demyelination of the CC as
shown by the Klüver-Barrera stain and by the increased ratio
between myelin basic protein (MBP) and the axonal marker
SMI312 (Fig. 5a, b). Myelin-associated glycoprotein (MAG) was
also reduced (Fig. 5c), while the microglial/macrophage marker
Iba1 was increased in the CC, reﬂecting the microglial reaction to
WM damage26 (Supplementary Fig. 8). Consistent with increased
BCAS-induced demyelination in ApoE4-TR mice, the oligoden-
drocyte marker Olig2 in the CC was reduced more in ApoE4-TR
than in WT or ApoE3-TR mice (Supplementary Fig. 9). BCAS did
not affect the reduction in pericyte vascular coverage observed at
baseline in the CC of ApoE4-TR mice (Supplementary
Fig. 2E–K). The integrity of the nodes of Ranvier was assessed by
the spatial relationship between the paranodal contactin-
associated protein Caspr and the sodium channel Nav1.6, enri-
ched at the nodes27. We found that BCAS increased the exposed
nodal Nav1.6 channels, resulting in a looser association with
Caspr and disruption of the nodal structure (Fig. 5d). BCAS also
impaired the performance at the Y maze and novel
object recognition tests, resulting in reduced arm alternation
and novel object exploration time (Fig. 5e, f). All the indices of
WM damage as well as cognitive performance were worse in
ApoE4-TR, when compared to WT and ApoeE3 mice (Fig. 5e, f).
No effect on locomotor activity was observed (Supplementary
Fig. 10)
Discussion
ApoE4, the major genetic risk factor for AD, has also emerged as
a signiﬁcant risk factor for SVD and WM lesions underlying
vascular cognitive impairment8–10. To investigate the potential
mechanisms of the effect we studied cerebrovascular structure
and function in ApoE3-TR and ApoE4-TR mice. We found that
ApoE4-TR mice have reduced resting CBF in the neocortex, an
effect associated with vascular rarefaction. We also found an
impairment of the major mechanisms linking cerebral perfusion
to the energy demands of the brain, such as neurovascular cou-
pling and endothelium-initiated microvascular responses20. These
functional alterations were not due to a generalized vasomotor
failure because the increase in CBF induced by the NO donor
SNAP, the smooth muscle relaxant adenosine, or hypercapnia
was not reduced. However, reduced cerebrovascular reactivity to
hypercapnia has been observed by fMRI in ApoE4+ indivi-
duals28. Therefore, the ApoE4 genotype, in addition to reducing
resting CBF, is also associated with a selective failure of funda-
mental homeostatic mechanisms matching cerebral perfusion
with the metabolic requirements of the brain tissue.
To explore the impact of such neurovascular dysfunction on
hypoxic-ischemic WM damage, we investigated whether the
ApoE genotype inﬂuences the WM damage produced by cerebral
hypoperfusion. There are several models of WM injury
mimicking SVD, each with strengths and weaknesses29. BCAS has
desirable features well suited for our purpose: (a) it leads to dif-
fuse WM damage in the CC, a watershed region like the human
subcortical WM; (b) the WM lesions are produced by hypo-
perfusion as in human WM disease;1,5,30 (c) with 0.18 mm
microcoils the lesions are restricted to the WM of the CC, sparing
the optic nerve and the hippocampus;24 (d) it avoids confounding
effects of pharmacological models (e.g., endothelin-1), in which
off-target effects cannot be ruled out;29 and (e) it leads to
quantiﬁable cognitive abnormalities attributed to damage of WM
tracts connecting the hippocampus to other brain regions







































































Fig. 2 CBF dysfunction in ApoE4-TR mice is reversed by MnTBAP. The increase in CBF induced by whisker stimulation (a, b) or by neocortical application
of acetylcholine (c), is attenuated in ApoE4-TR mice, but CBF response to neocortical application of adenosine (d) is not affected. Neocortical superfusion
with the ROS scavenger MnTBAP restores neurovascular function in ApoE4-TR mice (a–c). Data are expressed as means ± SEM. N= 5/group; * p < 0.05
from WT or ApoE3, or ApoE4+MnTBAP; one-way ANOVA and Tukey’s test
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microvascular perfusion, we demonstrated that BCAS reduces
baseline CBF in cerebral cortex assessed by ASL-MRI, as well as
in the microvasculature of the CC, assessed by 3-photon micro-
scopy. The ﬂow reduction was more marked in ApoE4-TR mice
and was associated with more severe WM hypoxia and more
extensive WM damage, involving both myelin and nodal-
paranodal structures. At the same time, ApoE4-TR mice exhib-
ited more severe cognitive impairment than ApoE3-TR or WT
mice. These observations collectively indicate that ApoE4 is









































































Fig. 3 Worse cortex CBF and CC hypoxia in ApoE4-TR mice after BCAS. a Neocortical CBF and mean arterial pressure (MAP) recorded at the indicated
times over 4 weeks before or after sham surgery (WT) or BCAS in WT (WT-Sham or -BCAS), ApoE3 (ApoE3-BCAS), and ApoE4 (ApoE4-BCAS) mice.
Right and left CBF values were not different and were averaged. The CBF reduction induced by BCAS is more marked in ApoE4-TR mice. b Representative
laser speckle images of CBF before or after BCAS in WT, ApoE3-TR, and ApoE4-TR mice, conﬁrming the greater CBF reduction in ApoE4-TR mice (see
Supplementary Fig. 7C for quantiﬁcation). Scale bar= 2mm. c The intensity of the hypoxyprobe signal, a marker of tissue hypoxia, is more pronounced in
the CC of ApoE4-TR mice, compared to WT or ApoE3-TR mice. Data are expressed as means ± SEM. Scale bar= 250 µm. N= 5/group; * p < 0.05 from
WT-sham; # p < 0.05 from WT and ApoE3-BCAS; one-way ANOVA and Tukey’s test. ALU arbitrary ﬂuorescent intensity units
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-06301-2 ARTICLE
NATURE COMMUNICATIONS |  (2018) 9:3816 | DOI: 10.1038/s41467-018-06301-2 | www.nature.com/naturecommunications 5
susceptibility to hypoperfusion-induced WM damage and cog-
nitive impairment, and provide a potential mechanism for the
increased WM damage in individuals carrying the ApoE4 gene in
the absence of other vascular risk factors.
Previous studies reported a reduction in resting CBF in ApoE4-
TR mice18,32, but the microvascular bases of the effect remained
unclear. Using 2-photon microscopy in carefully mapped vascular
networks, we found that in ApoE4-TR mice baseline micro-
vascular RBC ﬂux and diameter are not reduced in neocortical
arterioles, capillaries, and venules, but that vascular density is
reduced. Therefore, the reduction in resting CBF is most likely
due to a reduction in vascular density and not to reduced ﬂow in
individual microvessels. However, we cannot rule out the possi-
bility that a reduction in cerebral metabolism, tightly coupled to
CBF, could also contribute32. The deleterious effect of the
reduction in baseline ﬂow is compounded by the failure of critical
homeostatic mechanisms matching the delivery of CBF to the
metabolic needs of the tissue. In this regard, it is of interest that
both the increase in CBF produced by neural activity and by the
endothelium-dependent agonists ACh and BK are impaired in
ApoE4-TR mice. Functional hyperemia is mediated by multiple
vasoactive agents released by neurons and astrocytes, acting to
relax the local microvasculature20, whereas ACh and BK induced
vascular relaxation through distinct mediators, respectively NO
and cyclooxygenase-1 reaction products33,34. Therefore, the data
point to a global disruption of vasoregulatory mechanisms
involving both the endothelium and neurovascular pathways
mediating functional hyperemia. Since, oxidative stress occurs in
SVD in humans22 and in animal models of neurovascular
dysfunction35,36, we asked whether ROS were also involved in the
cerebrovascular effects of ApoE4. We found that the ROS sca-
venger MnTBAP is able to counteract in full the disturbance in
cerebrovascular regulation. This ﬁnding conﬁrms that the neu-
rovascular dysfunction is not the result of irretrievable vascular
damage. Furthermore, the observation that resting CBF, unlike
the regulatory dysfunction, was not ameliorated by ROS
scavenging suggests that the reduced baseline ﬂow is not a con-
sequence of the neurovascular dysfunction, which is consistent
with being due to vascular rarefaction instead.
The cellular bases of the neurovascular dysfunction remain to
be elucidated. Elegant studies focusing on the BBB have suggested
that pericyte loss in 9-month-old ApoE4-TR mice may result in
activation of the cyclophlin-A-NFκB-metalloprotease-9 pathway,










































































Fig. 4 Reduced CC ﬂow in ApoE4-TR mice before and after BCAS. a Rendering of in vivo 3-photon excited ﬂuorescence/third harmonic generation (3PEF/
THG) image stack that spans from the cortical surface to the white matter (WM) of the corpus callosum (CC) in ApoE3-TR mice. The vasculature was
visualized by the THG signal (white), and was also labeled with FITC-dextran (red). The images to the right (A1–A5) show 40-µm thick maximal
microvascular projections, centered at the indicated depths. Scale bar in A5= 50 µm. b–e Projections (20 µm thick) of 3PEF/THG image stacks and line
scans for capillaries in the CC, taken at the indicated depths from the cortical surface, of ApoE3 and ApoE4 mice at baseline and at one month after BCAS.
Scale bars in E are 10 µm and 50ms, respectively. f, g Plot of diameter (f) and RBC ﬂow speed (g) in individual CC capillaries at the depth between
800–1000 µm in the same mice at baseline and 4 weeks after BCAS (ApoE3 baseline n= 80 in four mice, ApoE4 baseline n= 85 in four mice, ApoE3
BCAS n= 118 in four mice, ApoE4 BCAS n= 73 in three mice). Data are expressed as means ± SEM. * p < 0.05 from ApoE3-Baseline; # p < 0.05 from
ApoE3-BCAS and ApoE4-Baseline; Kruskal-Wallis test
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Fig. 5 Worse CC injury and cognition in ApoE4-TR mice after BCAS. a Klüver-Barrera (KB) stain of the CC in sham-operated WT mice and in WT, ApoE3-
TR, and ApoE4-TR mice after BCAS. In a, as in b, c, d, related quantiﬁcation shown on the right. Scale bar= 250 µm. b Double-label immunohistochemistry
with myelin basic protein (MBP) and the pan-axonal neuroﬁlament marker SMI312 in the same groups of mice. Scale bar= 25 µm. c Myelin-associated
glycoprotein (MAG) immunohistochemistry in the same groups of mice. ALU: arbitrary ﬂuorescent intensity units. Scale bar= 250 µm. d Double-label
immunohistochemistry for the nodal Nav1.6 channels and the paranodal protein Caspr in the same groups of mice. Scale bar= 1.5 µm. e, f ApoE4-TR mice
have a more impaired arm alternation at the Y-maze test (e) and worse performance at the novel object recognition test (f). Data are expressed as means
± SEM. N= 5/group in a–d; N= 10/group in E–F; * p < 0.05 from WT-Sham; # p < 0.05 from WT- or ApoE3-BCAS; one-way ANOVA and Tukey’s test
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-06301-2 ARTICLE
NATURE COMMUNICATIONS |  (2018) 9:3816 | DOI: 10.1038/s41467-018-06301-2 | www.nature.com/naturecommunications 7
pericyte coverage and BBB dysfunction has also been reported
3 days after BCAS, but, as also shown in the present study,
pericyte coverage is re-established at 28 days37. Therefore, our
data that neurovascular coupling and endothelium-dependent
responses are altered at baseline and are completely reversible by
short-term ROS scavenging argue against pericyte loss being
directly responsible for the neurovascular dysfunction. However,
considering their critical role in neurovascular homeostasis and
WM integrity38, pericytes could contribute to the WM damage.
For example, pericyte induced loss of BBB integrity could pro-
mote ﬁbrinogen entry into the brain, resulting in oligodendrocyte
damage and demyelination5,39. This hypothesis, in addition to
hypoperfusion, would also implicate BBB disruption in the
mechanisms of WM damage, but it needs to be tested in future
studies. Similarly, the cellular sources of oxidative stress in
ApoR4-TR has not been identiﬁed. Interestingly, ApoE4 macro-
phages generate more ROS than those expressing ApoE2 or
ApoE323, but it remains to be established whether ApoE4 leads to
greater ROS production in vascular and perivascular cells.
A unique aspect of our study is the use of 3-photon microscopy
to explore microvascular perfusion in the WM of the CC in vivo,
a task unattainable at the imaging depth afforded by 2-photon
imaging. Using this technology, we demonstrated that WM
microvascular ﬂow is highly susceptible to reduction in cortical
CBF, linking the WM damage produced by BCAS to the hypoxia
caused by reduced cerebral perfusion. By imaging the CC
microcirculation we discovered that the reduction in ﬂow in
ApoE4-TR mice is not the result of vascular compression or tissue
edema30, since the microvascular diameter is not reduced. Rather,
we observed a reduction in RBC ﬂow, which, in turn, led to
reduced O2 delivery and WM hypoxia. By combining these
approaches, we established that in ApoE4-TR mice BCAS induces
a more severe reduction in RBC speed and hypoxia, thereby
providing insight into the mechanisms of the enhanced WM
damage observed in these mice. It is also of interest that in naive
ApoE4-TR mice baseline RBC speed was reduced in the CC, but
not in the cortex. This difference remains unexplained, but it may
be related to the precarious blood supply of the CC, which is
vascularized by separate arterial territories: penetrating arterioles
from the pial circulation and arterioles arising from the initial
segment the middle cerebral artery and traveling though the
striatum5. In this regard, our ﬁnding that in ApoE4-TR mice the
reduction in CC microvascular ﬂow is compounded by a reduc-
tion in microvascular density and pericyte coverage provides
further insight into the bases of the greater vulnerability of the CC
to hypoperfusion in these mice.
The ﬁndings shed light into the association of ApoE4 genotype,
SVD and WM damage11. ApoE4 could be involved both in the
pathogenesis of SVD as well as in the resulting WM damage. On
the one hand, ApoE4-related oxidative stress and endothelial
dysfunction may promote small vessels atherosclerosis and lipo-
hyalinosis, pathological hallmarks of SVD30,40. On the other
hand, reduced baseline CBF and neurovascular dysfunction
afforded by ApoE4 may exacerbate hypoperfusion and hypoxia in
the highly vulnerable subcortical WM. The combined effect of
these alterations is likely to act in concert to promote hypoxic-
ischemic WM damage leading to cognitive impairment.
In conclusion, we have demonstrated that the ApoE4 genotype
is associated with reduced resting cerebral perfusion, coupled
with a marked impairment of the major factors responsible for
maintaining an adequate blood supply to the working brain.
Furthermore, in conditions of cerebral hypoperfusion, ApoE4-TR
mice develop more severe WM damage and cognitive impair-
ment. The ﬁndings, collectively, provide insights into the
mechanistic bases for the increased susceptibility to SVD and
WM lesions in ApoE4 carriers, and highlight the prominent role
that genetic risk factors play in microvascular function and sus-
ceptibility to WM injury.
Methods
Mice. All procedures were approved by the Institutional Animal Care and Use
Committee of Weill Cornell Medicine and performed according to the ARRIVE
guidelines41, and, whenever appropriate, in a blinded fashion. Experiments were
performed in homozygous ApoE3-TR and ApoE4-TR mice on a C57BL/6 genetic
background42,43. ApoE2-TR mice were not used as controls since they develop
atherosclerosis on a normal diet44 and human ApoE2 may promote brain
hemorrhage45. C57BL/6 mice were used as wild-type (WT) controls. All mice were
males and aged 3–4 months.
Absolute CBF measurement by arterial spin labeling MRI. Imaging was per-
formed on a 7.0 Tesla 70/30 Bruker Biospec small animal MRI system46. The
animals were anesthetized with isoﬂurane (1–2%) and placed in the MRI. A volume
coil was used for transmission and a surface coil for reception. Anatomical localizer
images were acquired to ﬁnd the transversal slice corresponding to the somato-
sensory cortex (from −0.7 to 0.38 from Bregma)47. This position was used for
subsequent ASL imaging, which was based on a FAIR-RARE pulse sequence
labeling the inﬂowing blood by global inversion of the equilibrium magnetization.
Three averages of one axial slice were acquired with a ﬁeld of view of 15 × 15 mm,
spatial resolution of 0.234 × 0.234 × 2 mm3, echo time TE of 5.368 ms, effective TE
of 26.84 ms, repeat time TR of 10 s, and a RARE factor of 36. For computation of
CBF (ml/100 g/min), the Bruker ASL perfusion processing macro was used. Turbo-
RARE anatomical images were acquired with the same ﬁeld-of-view and orienta-
tion as the ASL images (resolution= 0.078 × 0.078 × 1mm3, TE= 48 ms, TR=
2200 ms, and a RARE factor of 10). The total scan time (ASL+ anatomical image)
was approximately 40 min.
Bilateral common carotid artery stenosis. Mice were anesthetized with iso-
ﬂurane (1–2%) in a mixture of oxygen-nitrogen with rectal temperature main-
tained at 37 °C24,31. Both common carotid arteries were dissected thorough a
midline incision and microcoils (internal diameter: 0.18 mm; Sawane Spring,
Japan) were placed around the arteries24,31, (Supplementary Fig. 7A). Sham-treated
mice underwent the same surgical procedure with no placement of microcoils.
Monitoring of CBF. CBF response to neural activity and to endothelium-
dependent and independent agonists: Anesthesia was induced with isoﬂurane
(1–2%) and maintained with urethane (750 mg/kg; i.p.) and α-chloralose (50 mg/
kg; i.p.). A femoral artery was cannulated for recording of arterial pressure and
collection of blood samples36,48,49. A 2 × 2 mm opening was drilled in the parietal
bone overlying the somatosensory cortex, the dura was removed, and the site was
superfused with a modiﬁed Ringer solution (37 °C; pH 7.3–7.4)48. Relative CBF was
continuously monitored at the site of superfusion with a LDF (Perimed). Arterial
blood pressure, blood gases, and rectal temperature were monitored and controlled.
CBF recordings were started after arterial pressure (MAP, 78–85 mmHg) and blood
gases (pO2, 120–140 mmHg; pO2, 33–40 mmHg; pH, 7.3–7.4) were in a steady
state36,48,49. For functional hyperemia, the whiskers were mechanically stimulated
for 60 s and the associated increase in CBF recorded over the somatosensory cortex.
To test endothelium-dependent responses, ACh (10 µM; Sigma) or BK
(50 µM; Sigma) was superfused over the cranial window, and the resulting changes
in CBF monitored. CBF responses to superfusion with SNAP (50 µM; Sigma) and
adenosine (400 µM; Sigma) were also tested. The CBF response to hypercapnia
(pCO2: 50–60 mmHg) was tested by introducing CO2 through the ventilator36,49.
Chronic CBF recordings after BCAS: CBF was monitored with LDF or LSI. For
LDF, mice were anesthetized with isoﬂurane (1.5–2%) in a mixture of oxygen and
nitrogen. Two ﬁber-optic probes were permanently glued to the parietal bone of
both hemispheres (3.5 mm lateral to bregma) (see Fig. 3a) and connected to a 2-
channel laser-Doppler ﬂowmeter (PF 5010, Perimed) for longitudinal CBF
monitoring in the same mouse. Baseline CBF was obtained 30 min before BCAS. At
the same time, pre-stenosis MAP was recorded through a femoral artery catheter.
Then, BCAS was induced by placing microcoils. For CBF measurement with LSI
(Omegazone; Omegawave), mice were anesthetized with 1–2% isoﬂurane, and the
scalp was removed to expose the skull. The following day, mice were re-
anesthetized and the exposed skull was illuminated by with laser light (780 nm).
The scattered light was ﬁltered and detected by a CCD camera positioned over the
skull. The raw speckle images were used to compute speckle contrast, which in the
mouse neocortex reﬂects the velocity of moving RBCs up to a depth of ≈700 µm,
but weighted more towards surface vessels50. Color-coded blood ﬂow images were
obtained in high-resolution mode (639 × 480 pixels; 1 image/s) and the sample
frequency was 60 Hz. One CBF image was generated by averaging numbers
obtained from 20 consecutive raw speckle images. The recordings were initiated
after the CBF was stable, and ﬁve recordings of blood ﬂow image were averaged.
The CBF reduction induced by BCAS was calculated as a percentage of the pre-
stenosis CBF value. For both LDF and LSI, CBF changes were recorded 2 hours, 4
hours, 2 weeks, and 4 weeks after BCAS.
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Multiphoton imaging. Optical access to brain was achieved through a long-term
glass-covered cranial window implanted between lambda and the bregma (8 wide x
4 mm long)51. Animals were anesthetized using isoﬂurane (1.5–2% in oxygen) and
maintained at 37 ˚C rectal temperature. Bilateral craniotomies were performed over
parietal cortex using a dental drill and sealed with a glass coverslip. All mice
recovered at least 21 days before in vivo imaging and BCAS surgery.
Multiphoton excited ﬂuorescent microscopy: Imaging was conducted using a
custom multiphoton microscope. For 3-photon excited ﬂuorescence (3PEF)
imaging with 1300 nm laser light, we used an optical parametric ampliﬁer (OPA)
(Coherent, Opera-F) that was seeded by a diode-pumped femtosecond laser (40 µJ/
pulse at 1 MHz; Coherent, Monaco), producing sub-100-fs pulses at 1-MHz
repetition rate with up to 1-µJ energy. Dispersion for 1300-nm excitation was
compensated with an SF11 prism pair. For imaging, the excitation laser was
scanned with a line rate of ~1 kHz with galvanometric scanners. Images were
acquired with an Olympus XLPlan N 25 × 1.05 NA objective. Signal was collected
using custom detection optics using following emission ﬁlters (center wavelength/
bandwidth): 417/60 (third harmonic generation, THG) and 494/41 (ﬂuorescein
isothiocyanate, FITC), separated with a long-pass dichroic with a cutoff at 458 nm.
For 2-photon excited ﬂuorescence (2PEF) imaging, a Ti:Sapphire oscillator
(Chameleon, Coherent) at 800-nm wavelength was used, and FITC emission was
collected with the same ﬁlter. Image acquisition was controlled by ScanImage
software52.
Imaging cortical and subcortical blood ﬂow: Cortical blood ﬂow was measured
using 2PEF imaging, while CC blood ﬂow was characterized using 3PEF
microscopy, all on a microscope that was equipped with both excitation laser
sources. For cortical measurements using 2PEF imaging, the blood plasma was
labeled with 2.5% w/v FITC 70 kDa conjugated dextran (Invitrogen) diluted in
sterile saline and retro-orbitally injected (50 µl) before imaging. We took 3D image
stacks and identiﬁed individual arterioles, capillaries, and venules (noting both
spatial location and topological position in the vascular hierarchy) for
measurement of vessel diameter and RBC speed using image stacks and lines
cans19. RBC speed measurements were made at a depth of 200 µm in all groups of
animals.
For 3PEF measurements of CC capillaries, we used the signal from FITC-
dextran to identify vessels and measure vessel diameter. However, we used the
endogenous THG signal from RBC53,54 for the line scan measurements
(Supplementary Fig. 11), since THG provides a higher contrast signal compared to
the 3PEF of FITC-dextran, enabling higher ﬁdelity measurement of blood ﬂow
speed53,54. The 3PEF imaging was performed between 800 and 1000 µm (typically
900 µm), depending on the depth of the CC relative to the pial surface. In addition
to the depth (>800 µm), the localization to the CC was veriﬁed by: (a) the
distinctive pattern of the THG signal arising from the WM, reﬂecting the more
compact WM tracts of the CC, and (b) the linear pattern of microvessels and
reduced vascular density indicated by the FITC signal (Fig. 4A5). All images were
processed using ImageJ (National Institutes of Health), and blood cell speed was
calculated by custom written MATLAB code19,55.
Detection of hypoxia by the hypoxyprobe. Hypoxia was detected using
HypoxyprobeTM-1 kit (Hypoxyprobe Inc, Burlington, MA) according to the
manufacturer’s instruction. Four weeks after BCAS, mice were injected with
Hypoxyprobe-1 (60 mg/Kg; i.p.). One hour later, anesthetized mice were trans-
cardially perfused. Brains were removed, postﬁxed, and sectioned (16 µm) with a
cryostat. Brain sections were incubated with a monoclonal anti-hypoxyprobe
antibody (1:50) at room temperature for 2 h. Images were obtained with a confocal
laser-scanning microscope (Leica SP5), quantiﬁed by ImageJ (NIH) and difference
in stain intensity expressed as arbitrary luminescent unit.
Evaluation of WM injury. Four weeks after BCAS, anesthetized mice were perfused
transcardially36,49. Brains were removed, postﬁxed overnight, and sectioned with
cryostat (thickness of 12 μm) or vibratome (40 µm). For immunohistochemical
evaluation of BCAS-induced WM injury the following antibodies were used with the
appropriate secondary antibodies (Supplementary Table 1): anti-cluster of differ-
entiation 31 (CD31) (rat; 1:30; BD Pharmingen), anti-glucose transporter 1 (Glut1)
(rabbit; 1:500; Millipore Sigma), anti-myelin basic protein (MBP) (rat; 1:500; Mil-
lipore Sigma), the neuroﬁlament anti-SMI312 (mouse;1:500, Covance), anti-myelin-
associated glycoprotein (MAG) (10 µg/ml; Millipore Sigma)56, anti-contactin-
associated protein (Caspr) (mouse; 1:300, Millipore Sigma)27, anti-voltage-gated
sodium channel (Nav) 1.6 (Nav 1.6) (rabbit; 1:200, Alomone)27, anti-Ionized cal-
cium binding adaptor molecule 1 (Iba1) (rabbit; 1:500; Wako), anti-oligodendrocyte
transcription factor 2 (Olig2) (rabbit; 1:200; Millipore Sigma), or anti-synaptophysin
(mouse; 1:100; R&D Systems). Images were obtained with a confocal laser-scanning
microscope (Leica SP5) and analyzed using ImageJ. The Klüver-Barrera stain was
performed using the Luxol Fast Blue Stain Kit (ScyTek Laboratory Inc.). Brains were
harvested after transcardiac perfusion with PBS and 4% PFA, sectioned with a
vibratome (thickness 40 µm), and the positive (blue stained) area in the CC was
quantiﬁed by ImageJ.
Cytoplasmic Ca2+ in dissociated neocortical neurons. Coronal cortical slices
(350 µm in thickness) were cut from the brain of 3-month old WT, ApoE3-TR and
ApoE4-TR mice and incubated aCSF containing Pronase 0.02% (w/v), thermolysin
(0.02%) at 36 °C (Sigma Aldrich)57. The tissue was mechanically dissociated and
incubated with the Ca2+ indicator Fura-2/AM (20 μmol/l, Life Fisher)58. Fura-2/
AM-loaded cells transferred to polyornithine-coated glass-bottom Petri dish
(Warner Instruments, CT). Images were acquired on a Nikon 300 inverted
microscope by using a ﬂuorite oil-immersion lens (Nikon CF UV-F X40; N.A., 1.3)
58. Fura-2/AM was alternately excited through narrow bandpass ﬁlters (340 and
380 nm). An intensiﬁed CCD camera (Retiga ExI) recorded the ﬂuorescence
emitted by the indicator (510 ± 4 nm). After background subtraction, ﬂuorescence
measurements were obtained from cell bodies of 3–5 neurons in randomly selected
ﬁelds before and after perfusion of the cells with NMDA (40 μmol/l) for 20 min.
Fluorescence ratios (340/380 nm) were calculated for each pixel by using a standard
formula59. At the end of the experiment, the viability of the preparation was
veriﬁed by testing the Ca2+ response to the Ca2+ ionophore A2318758.
Cognitive testing. We elected to use the Y-maze and novel object recognition
because these tests: (a) are sensitive to the cognitive effects of BCAS35,60–63, (b) rely
on WM tracts connecting the hippocampus to the cortex and other brain regions64
and, as such, are appropriate in a model of WM damage, (c) rely on the sponta-
neous behavior of mice and (c) do not required aversive environments or starving
of the mice65–67.
Y-maze spontaneous alternation behavior: mice were placed into one of the
arms of the maze (start arm) and allowed to explore only two of the three arms for
5 min (training trial). The closed arm was opened in the test trial, serving as the
novel arm. After a 30-min interval between trials, the mice were returned to the
same start arm and were allowed to explore all three arms for 5 min (test trial).
Sessions were video recorded and analyzed using AnyMaze (San Diego
Instruments) in a double-blinded fashion. Spontaneous alternation was evaluated
by scoring the order of entries into each arm during the 5 min of the test trial.
Spontaneous arm alternation (%) was deﬁned as: number of arm alternations/(total
number of arm visits-2) x 100.
Novel object recognition: the test was performed in two consecutive days. On
day one, mice were placed in the center of an empty open box and allowed to
explore for 5 min. The box was cleaned with 70% ethanol between trials. On day 2,
the mice were placed back to an open box with two identical objects in the center
and allowed to explore for 5 min. Thirty minutes later, mice were exposed again to
a familiar and a novel object, and allowed to explore for 5 min. The exploring
activity (facing, touching, or snifﬁng the object) was monitored and analyzed using
AnyMaze in a double-blinded manner, and the percent of the time spent exploring
the novel vs. familiar objects was calculated.
Data analysis. Statistical analysis was performed using GraphPad Prism
(GraphPad Software, Inc). Histological and cerebrovascular analyses were
conducted in a blinded fashion. Samples and animals were randomized by a
random number generator (www.random.org). No animals were excluded. The
number of mice required for assessing statistical signiﬁcance of pre-speciﬁed
effects was estimated by power analysis based on preliminary results and pre-
vious experience with the models used in the lab. Normality was tested using
D’Agostino-Pearson normality test (GraPad Prism) before running appropriate
statistical tests. Two-group comparisons were analyzed by the two-tailed t-test
and multiple comparisons were evaluated by the analysis of variance and
Tukey’s test, after testing for equality of variance. The data in Fig. 4G were
evaluated by the nonparametric Kruskal-Wallis test. Differences were con-
sidered statistically signiﬁcant for probability values less than 0.05. Data are
expressed as means ± SEM.
Data availability
The authors declare that the data supporting the ﬁndings of this study are available
within the article and Supplementary Information Files or available from the authors
upon reasonable request.
Received: 17 May 2018 Accepted: 14 August 2018
References
1. Dichgans, M. & Leys, D. Vascular cognitive impairment. Circ. Res. 120,
573–591 (2017).
2. Hughes, T. M. et al. Arterial stiffness and dementia pathology: Atherosclerosis
Risk in Communities (ARIC)-PET Study. Neurology 90, e1248–e1256 (2018).
3. Lee, S. et al. White matter hyperintensities are a core feature of Alzheimer’s
disease: evidence from the dominantly inherited Alzheimer network. Ann.
Neurol. 79, 929–939 (2016).
4. Provenzano, F. A. et al. White matter hyperintensities and cerebral
amyloidosis: necessary and sufﬁcient for clinical expression of Alzheimer
disease? JAMA Neurol. 70, 455–461 (2013).
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-06301-2 ARTICLE
NATURE COMMUNICATIONS |  (2018) 9:3816 | DOI: 10.1038/s41467-018-06301-2 | www.nature.com/naturecommunications 9
5. Iadecola, C. The pathobiology of vascular dementia. Neuron 80, 844–866
(2013).
6. Gorelick, P. B. et al. Vascular contributions to cognitive impairment and
dementia: a statement for healthcare professionals from the American Heart
Association/American Stroke Association. Stroke 42, 2672–2713 (2011).
7. Haffner, C., Malik, R. & Dichgans, M. Genetic factors in cerebral small vessel
disease and their impact on stroke and dementia. J. Cereb. Blood. Flow. Metab.
36, 158–171 (2016).
8. Davidson, Y. et al. Apolipoprotein E epsilon4 allele frequency in vascular
dementia. Dement. Geriatr. Cogn. Disord. 22, 15–19 (2006).
9. Luo, X. et al. Associations between APOE genotype and cerebral small-vessel
disease: a longitudinal study. Oncotarget 8, 44477–44489 (2017).
10. Sun, J. H. et al. Genetics of vascular dementia: systematic review and meta-
analysis. J. Alzheimers Dis. 46, 611–629 (2015).
11. Schilling, S. et al. APOE genotype and MRI markers of cerebrovascular
disease: systematic review and meta-analysis. Neurology 81, 292–300 (2013).
12. Rojas, S. et al. Higher prevalence of cerebral white matter hyperintensities in
homozygous APOE-varepsilon4 allele carriers aged 45-75: results from the
ALFA study. J. Cereb. Blood. Flow. Metab. 38, 250–261 (2018).
13. Sudre, C. H. et al. APOE epsilon4 status is associated with white matter
hyperintensities volume accumulation rate independent of AD diagnosis.
Neurobiol. Aging 53, 67–75 (2017).
14. Haller, S. et al. Cerebral microbleeds: imaging and clinical signiﬁcance.
Radiology 287, 11–28 (2018).
15. Zlokovic, B. V. Cerebrovascular effects of apolipoprotein E: implications for
Alzheimer disease. JAMA Neurol. 70, 440–444 (2013).
16. Deane, R. et al. apoE isoform-speciﬁc disruption of amyloid beta peptide
clearance from mouse brain. J. Clin. Invest. 118, 4002–4013 (2008).
17. Tai, L. M. et al. The role of APOE in cerebrovascular dysfunction. Acta
Neuropathol. 131, 709–723 (2016).
18. Bell, R. D. et al. Apolipoprotein E controls cerebrovascular integrity via
cyclophilin A. Nature 485, 512–516 (2012).
19. Santisakultarm, T. P. et al. In vivo two-photon excited ﬂuorescence
microscopy reveals cardiac- and respiration-dependent pulsatile blood ﬂow in
cortical blood vessels in mice. Am. J. Physiol. Heart Circ. Physiol. 302,
H1367–H1377 (2012).
20. Iadecola, C. The neurovascular unit coming of age: a journey through
neurovascular coupling in health and disease. Neuron 96, 17–42 (2017).
21. Lecrux, C. et al. Pyramidal neurons are “neurogenic hubs” in the
neurovascular coupling response to whisker stimulation. J. Neurosci. 31,
9836–9847 (2011).
22. Back, S. A. et al. Selective vulnerability of preterm white matter to oxidative
damage deﬁned by F2-isoprostanes. Ann. Neurol. 58, 108–120 (2005).
23. Jofre-Monseny, L. et al. Differential effects of apolipoprotein E3 and E4 on
markers of oxidative status in macrophages. Br. J. Nutr. 97, 864–871 (2007).
24. Shibata, M. et al. Selective impairment of working memory in a mouse model
of chronic cerebral hypoperfusion. Stroke 38, 2826–2832 (2007).
25. Ouzounov, D. G. et al. In vivo three-photon imaging of activity of GCaMP6-
labeled neurons deep in intact mouse brain. Nat. Methods 14, 388–390 (2017).
26. Hattori, Y. et al. A novel mouse model of subcortical infarcts with dementia. J.
Neurosci. 35, 3915–3928 (2015).
27. Arancibia-Carcamo, I. L. & Attwell, D. The node of Ranvier in CNS
pathology. Acta Neuropathol. 128, 161–175 (2014).
28. Suri, S. et al. Reduced cerebrovascular reactivity in young adults carrying the
APOE epsilon4 allele. Alzheimer’s Dement. 11, 648–657 (2015). e641.
29. Hainsworth, A. H. et al. Translational models for vascular cognitive
impairment: a review including larger species. BMC Med. 15, 16 (2017).
30. Wardlaw, J. M., Smith, C. & Dichgans, M. Mechanisms of sporadic cerebral
small vessel disease: insights from neuroimaging. Lancet Neurol. 12, 483–497
(2013).
31. Coltman, R. et al. Selective white matter pathology induces a speciﬁc
impairment in spatial working memory. Neurobiol. Aging 32, 2324
e2327–2312 (2011).
32. Lin, A. L. et al. Rapamycin rescues vascular, metabolic and learning deﬁcits in
apolipoprotein E4 transgenic mice with pre-symptomatic Alzheimer’s disease.
J. Cereb. Blood. Flow. Metab. 37, 217–226 (2017).
33. Girouard, H., Park, L., Anrather, J., Zhou, P. & Iadecola, C. Cerebrovascular
nitrosative stress mediates neurovascular and endothelial dysfunction induced
by angiotensin II. Arterioscler. Thromb. Vasc. Biol. 27, 303–309 (2007).
34. Niwa, K., Haensel, C., Ross, M. E. & Iadecola, C. Cyclooxygenase-1
participates in selected vasodilator responses of the cerebral circulation. Circ.
Res. 88, 600–608 (2001).
35. Faraco, G. et al. Perivascular macrophages mediate the neurovascular and
cognitive dysfunction associated with hypertension. J. Clin. Invest. 126,
4674–4689 (2016).
36. Park, L. et al. Brain perivascular macrophages initiate the neurovascular
dysfunction of Alzheimer abeta peptides. Circ. Res. 121, 258–269 (2017).
37. Liu Q., et al. Experimental chronic cerebral hypoperfusion results in decreased
pericyte coverage and increased blood-brain barrier permeability in the corpus
callosum. J Cereb Blood Flow Metab. 271678X17743670 (2017).
38. Montagne, A. et al. Pericyte degeneration causes white matter dysfunction in
the mouse central nervous system. Nat. Med. 24, 326–337 (2018).
39. Petersen, M. A., Ryu, J. K. & Akassoglou, K. Fibrinogen in neurological
diseases: mechanisms, imaging and therapeutics. Nat. Rev. Neurosci. 19,
283–301 (2018).
40. Brown, W. R. & Thore, C. R. Review: cerebral microvascular pathology in
ageing and neurodegeneration. Neuropathol. Appl. Neurobiol. 37, 56–74
(2011).
41. Kilkenny, C. et al. Animal research: reporting in vivo experiments–the
ARRIVE guidelines. J. Cereb. Blood. Flow. Metab. 31, 991–993 (2011).
42. Sullivan, P. M. et al. Targeted replacement of the mouse apolipoprotein E gene
with the common human APOE3 allele enhances diet-induced
hypercholesterolemia and atherosclerosis. J. Biol. Chem. 272, 17972–17980
(1997).
43. Wang, C. et al. Human apoE4-targeted replacement mice display synaptic
deﬁcits in the absence of neuropathology. Neurobiol. Dis. 18, 390–398 (2005).
44. Sullivan, P. M., Mezdour, H., Quarfordt, S. H. & Maeda, N. Type III
hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from
gene replacement of mouse Apoe with human Apoe*2. J. Clin. Invest. 102,
130–135 (1998).
45. Bifﬁ, A. et al. APOE genotype and extent of bleeding and outcome in lobar
intracerebral haemorrhage: a genetic association study. Lancet Neurol. 10,
702–709 (2011).
46. Jackman, K. et al. Progranulin deﬁciency promotes post-ischemic blood-brain
barrier disruption. J. Neurosci. 33, 19579–19589 (2013).
47. Paxinos, G., & FranklinK. B. J.. The Mouse Brain in Stereotaxic Coordinates.
(Elsevier Academic Press, London, 2004).
48. Iadecola, C. et al. SOD1 rescues cerebral endothelial dysfunction in mice
overexpressing amyloid precursor protein. Nat. Neurosci. 2, 157–161 (1999).
49. Uekawa, K. et al. Obligatory role of EP1 receptors in the increase in cerebral
blood ﬂow produced by hypercapnia in the mice. PLoS ONE 11, e0163329
(2016).
50. Dunn, A. K., Bolay, H., Moskowitz, M. A. & Boas, D. A. Dynamic imaging of
cerebral blood ﬂow using laser speckle. J. Cereb. Blood. Flow. Metab. 21,
195–201 (2001).
51. Holtmaat, A. et al. Long-term, high-resolution imaging in the mouse
neocortex through a chronic cranial window. Nat. Protoc. 4, 1128–1144
(2009).
52. Pologruto, T. A., Sabatini, B. L. & Svoboda, K. ScanImage: ﬂexible software for
operating laser scanning microscopes. Biomed. Eng. Online 2, 13 (2003).
53. Dietzel, S. et al. Label-free determination of hemodynamic parameters in the
microcirculaton with third harmonic generation microscopy. PLoS ONE 9,
e99615 (2014).
54. Farrar, M. J., Wise, F. W., Fetcho, J. R. & Schaffer, C. B. In vivo imaging of
myelin in the vertebrate central nervous system using third harmonic
generation microscopy. Biophys. J. 100, 1362–1371 (2011).
55. Kim, T. N. et al. Line-scanning particle image velocimetry: an optical
approach for quantifying a wide range of blood ﬂow speeds in live animals.
PLoS ONE 7, e38590 (2012).
56. Li, C., Trapp, B., Ludwin, S., Peterson, A. & Roder, J. Myelin associated
glycoprotein modulates glia-axon contact in vivo. J. Neurosci. Res. 51, 210–217
(1998).
57. Coleman, C. G. et al. Chronic intermittent hypoxia induces NMDA receptor-
dependent plasticity and suppresses nitric oxide signaling in the mouse
hypothalamic paraventricular nucleus. J. Neurosci. 30, 12103–12112 (2010).
58. Park, L. et al. The key role of transient receptor potential melastatin-2
channels in amyloid-beta-induced neurovascular dysfunction. Nat. Commun.
5, 5318 (2014).
59. Kawano, T. et al. Prostaglandin E2 EP1 receptors: downstream effectors of
COX-2 neurotoxicity. Nat. Med. 12, 225–229 (2006).
60. Park, L. et al. Innate immunity receptor CD36 promotes cerebral amyloid
angiopathy. Proc. Natl. Acad. Sci. USA 110, 3089–3094 (2013).
61. Lee E. S., et al. A mouse model of subcortical vascular dementia reﬂecting
degeneration of cerebral white matter and microcirculation. J Cereb Blood
Flow Metab. 271678X17736963 (2017).
62. Toyama, K. et al. Apoptosis signal-regulating kinase 1 is a novel target
molecule for cognitive impairment induced by chronic cerebral
hypoperfusion. Arterioscler. Thromb. Vasc. Biol. 34, 616–625 (2014).
63. Zuloaga, K. L. et al. High fat diet-induced diabetes in mice exacerbates
cognitive deﬁcit due to chronic hypoperfusion. J. Cereb. Blood. Flow. Metab.
36, 1257–1270 (2016).
64. Aggleton, J. P. & Pearce, J. M. Neural systems underlying episodic memory:
insights from animal research. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 356,
1467–1482 (2001).
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-06301-2
10 NATURE COMMUNICATIONS |  (2018) 9:3816 | DOI: 10.1038/s41467-018-06301-2 | www.nature.com/naturecommunications
65. Dellu, F., Contarino, A., Simon, H., Koob, G. F. & Gold, L. H. Genetic
differences in response to novelty and spatial memory using a two-trial
recognition task in mice. Neurobiol. Learn. Mem. 73, 31–48 (2000).
66. Vorhees, C. V. & Williams, M. T. Assessing spatial learning and memory in
rodents. Ilar. J. 55, 310–332 (2014).
67. Wenk, G. L. Assessment of spatial memory using the radial arm maze and
Morris water maze. Curr. Protoc. Neurosci. https://doi.org/10.1002/
0471142301.ns0805as26 (2004).
Acknowledgements
This study is supported by grants (R01-NS100447, C.I.; R01-NS097805, L.P.) from
National Institute on Aging (NIA) and National Institute of Neurological Disorders and
Stroke (NINDS). Y.H. is supported by fellowships from Japan Heart Foundation/Bayer
Research Grant Abroad, The Uehara Memorial Foundation Research Fellowship, and
Japan Society for the Promotion of Science Overseas Research Fellowships. Support from
the Feil Family Foundation is gratefully acknowledged.
Author contributions
K.K. and Y.H. conducted the experiments and performed the data analysis; S.J.A. con-
ducted the two- and three-photon microscopy experiments; I.B., K.U., and A.C. con-
tributed to the histology experiments; G.W. and A.H performed the Ca2+ imaging
experiments; H.U.V. contributed to the ASL- and T2-MRI experiments and data analysis;
C.S. supervised and analyzed the experiments involving the two- and three-photon
experiments; L.Z., S.M.P., L.P., and C.I. supervised the research and wrote the
manuscript.
Additional information
Supplementary Information accompanies this paper at https://doi.org/10.1038/s41467-
018-06301-2.
Competing interests: The authors declare no competing interests.
Reprints and permission information is available online at http://npg.nature.com/
reprintsandpermissions/
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional afﬁliations.
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The images or other third party
material in this article are included in the article’s Creative Commons license, unless
indicated otherwise in a credit line to the material. If material is not included in the
article’s Creative Commons license and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly from
the copyright holder. To view a copy of this license, visit http://creativecommons.org/
licenses/by/4.0/.
© The Author(s) 2018
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-06301-2 ARTICLE
NATURE COMMUNICATIONS |  (2018) 9:3816 | DOI: 10.1038/s41467-018-06301-2 | www.nature.com/naturecommunications 11
